Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 228,908,147 papers from all fields of science
Search
Sign In
Create Free Account
Stage IIA Colon Cancer
Known as:
Stage IIA Colon Cancer AJCC v7
Stage IIA includes: T3, N0, M0. T3: Tumor invades through the muscularis propria into pericolorectal tissues. N0: No regional lymph node metastasis…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
20 relations
APC gene
Abdominal Pain
BRAF gene
Colon structure (body structure)
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Survival benefit of adjuvant chemotherapy for patients with poorly differentiated stage IIA colon cancer
Qi Liu
,
Dakui Luo
,
+4 authors
Xinxiang Li
Journal of Cancer
2019
Corpus ID: 71715096
Background: The effect of adjuvant chemotherapy on stage II colon cancer remains constantly controversial. Recently, however…
Expand
2019
2019
Colon Adenocarcinoma Stage IIA—Can We Predict Relapse?
J. Pinto
,
I. Rosa
,
+5 authors
A. D. Pereira
Journal of Gastrointestinal Cancer
2019
Corpus ID: 73478394
Purpose To determine prognostic factors for stage IIA colon cancer (CC) recurrence in patients undergoing curative intent surgery…
Expand
2019
2019
Indication for and Effect of Adjuvant Chemotherapy for Stage IIa (T3N0M0) Colon Cancer
C. Jeon
,
Min Ki Kim
,
I. Lee
Annals of Coloproctology
2019
Corpus ID: 208039979
Purpose The efficacy of adjuvant chemotherapy (AC) in stage IIa colon cancer is controversial. This study aimed to investigate…
Expand
2018
2018
Abstract 3313: Epigenetic biomarkers of prognosis in stage IIA colon cancer
Sara Pagotto
,
E. Porcellini
,
+12 authors
A. Veronese
Molecular and Cellular Biology / Genetics
2018
Corpus ID: 81141225
Adjuvant therapy is a systemic treatment administered after primary tumor resection to reduce the risk of relapse and death in…
Expand
Review
2017
Review
2017
Prospective Evaluation of a 12‐Gene Assay on Patient Treatment Decisions and Physician Confidence in Mismatch Repair Proficient Stage IIA Colon Cancer
L. Renfro
,
N. Zhang
,
M. Lopatin
,
C. Chao
,
S. Alberts
Clinical colorectal cancer
2017
Corpus ID: 3633345
Review
2014
Review
2014
Prospective evaluation of a 12-gene assay on patient treatment decisions and physician confidence in mismatch repair-proficient (MMR-P) stage IIa colon cancer patients.
S. Alberts
,
L. Renfro
,
+4 authors
M. Lee
2014
Corpus ID: 78343569
396 Background: The 12-gene Oncotype DXColon Cancer Assay is clinically validated as a predictor of recurrence risk in stage II…
Expand
2012
2012
Evaluation of the prognostic utility of miRNA and multiple genetic markers in stage IIA colon cancer.
E. Mambo
,
T. Sanford
,
+4 authors
L. Garmire
2012
Corpus ID: 201161720
3630 Background: The variable prognoses of stage II colon cancer subjects have provoked a therapeutic dilemma of who should…
Expand
2012
2012
Prognostic factors of stage IIa colon cancer
Lin Wang
,
J. Gu
,
Yi-fan Peng
2012
Corpus ID: 78791296
Review
2012
Review
2012
Elevated Preoperative Carcinoembryonic Antigen (CEA) and Ki67 Is Predictor of Decreased Survival in IIA Stage Colon Cancer
Yi-fan Peng
,
Lin Wang
,
J. Gu
World Journal of Surgery
2012
Corpus ID: 24007740
BackgroundThe present study was designed to investigate the prognostic factors of stage IIA (pT3N0M0) colon cancer.MethodsWe…
Expand
2011
2011
NLR as predictor: a concern in laboratory medicine aspect
V. Wiwanitkit
International Journal of Colorectal Disease
2011
Corpus ID: 6538208
Dear Editor: I read the recent publication “Elevated preoperative neutrophil to lymphocyte ratio (NLR) predicts risk of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE